| Issue |
Title |
File |
| Vol 24, No 1 (2022) |
NGAL and KIM-1 – early urinary biomarkers of nephrotoxicity mediated by cisplatin: Observational study |
(Rus)
|
|
Grechukhina K.S., Chebotareva N.V., Zhukova L.G., Dorofeev A.S., Krasnova T.N.
|
| Vol 13, No 2 (2011) |
Nilotinib i dazatinibv 1-y linii terapii bol'nykhkhronicheskim mieloleykozomv khronicheskoy faze |
|
|
Lazorko N.S., Lomaia E.G., Sbityakova E.I., Zaritskiy A.Y.
|
| Vol 15, No 1 (2013) |
Non-Hodgkin’s lymphomas of the organ of vision (a review of literature) |
|
|
Guzenko E.S.
|
| Vol 20, No 4 (2018) |
Non-small cell lung cancer with the tracheal bifurcation involvement. Carinal pneumonectomy or chemo-radiation therapy? |
(Rus)
|
|
Dadyev I.A., Davydov M.M., Shogenov M.S., Abdullaev A.G., Ibraev M.A., Filatov A.A.
|
| Vol 20, No 1 (2018) |
Nosological structure of patients in oncohematology department at the Loginov Moscow Clinical Scientific Center for 2016 year |
(Rus)
|
|
Pivnik A.V., Dudina G.A., Petrenko A.A., Tumanova M.V., Stuklov N.I., Leyghton R.A., Nikerova L.I., Dubnitskaya M.G., Mukhin O.V., Kremneva N.V., Fedorova V.S.
|
| Vol 22, No 4 (2020) |
Novel therapeutic strategies for patients with metastatic triple-negative breast cancer |
(Rus)
|
|
Ganshina I.P., Gordeeva O.O., Manukian M.S.
|
| Vol 4, No 3 (2002) |
Novoe napravlenie v lechenii khronicheskogo bolevogo sindroma u onkologicheskikh bol'nykh |
|
|
Isakova M.E., Pavlova Z.V., Bryuzgin V.V.
|
| Vol 10, No 2 (2008) |
Novoe v terapii gastrointestinal'nykh stromal'nykh opukholey –ad\"yuvantnaya terapiya |
|
|
Poddubnaya I.V.
|
| Vol 3, No 1 (2001) |
Novoe v terapii raka molochnoy zhelezy: neoad\"yuvantnaya gormonoterapiya |
|
|
Semiglazov V.F., Semiglazov V.V., Ivanov V.G., Bershteyn L.M., Tsyrlina E.V., Zhil'tsova E.K., Arzumanov A.S., Nurgaziev K.S.
|
| Vol 6, No 2 (2004) |
Novye aktsenty v endokrinnoy terapii raka molochnoy zhelezy |
|
|
Makarenko N.P.
|
| Vol 9, No 1 (2007) |
Novye gorizonty immunoterapii nekhodzhkinskikh limfom iz kletok zony mantii |
|
|
Poddubnaya I.V.
|
| Vol 3, No 4 (2001) |
Novye immunologicheskie markery (CD71 , LU-BCRU-G7), vzaimosvyazannye s prognozom raka molochnoy zhelezy |
|
|
Tupitsyn N.N., Letyagin V.P., Panichenko A.V., Vasil'ev M.B., Shinkarev S.A., Artamonova E.V., Ognerubov N.A., Ermilova V.D., Ryazantseva S.N.
|
| Vol 13, No 3 (2011) |
Novye lekarstvennye preparatyv terapii raka predstatel'noyzhelezy, rezistentnogo k kastratsii |
|
|
Petrov S.B., Nosov A.K., Vorob'ev N.A.
|
| Vol 13, No 4 (2011) |
Novye rekomendatsii EORTC po primeneniyugranulotsitarno-koloniestimuliruyushchegofaktora (G-KSF) dlya snizheniya riskarazvitiya febril'noy neytropenii (FN)u vzroslykh patsientov s limfomamii solidnymi opukholyami.Algoritm opredeleniya riska razvitiya FNi primenenie G-KSF |
|
|
- -.
|
| Vol 13, No 2 (2011) |
Novye strategii terapii zlokachestvennykhlimfoproliferativnykh zabolevaniyobsuzhdalis' v Sankt-Peterburgena forume onkogematologov |
|
|
- -.
|
| Vol 3, No 3 (2001) |
Novye vozmozhnosti endokrinnoy terapii raka molochnoy zhelezy |
|
|
Makarenko N.P., Poddubnaya I.V.
|
| Vol 10, No 1 (2008) |
Novye vozmozhnosti targetnoy terapii neyropaticheskoy boli v onkologii |
|
|
Abuzarova G.R., Prokhorov B.M., Sokolenov A.S., Shakhnovich E.B.
|
| Vol 14, No 2 (2012) |
Novye vozmozhnosti targetnoy terapii v onkodermatologii |
|
|
- -.
|
| Vol 13, No 2 (2011) |
Novye vozmozhnosti targetnoy terapiirasprostranennogo raka pochki |
|
|
- -.
|
| Vol 3, No 2 (2001) |
Novye vozmozhnosti v terapii zrelokletochnykh nekhodzhkinskikh limfom: preparat "Mabtera" - nastoyashchee i budushchee |
|
|
Poddubnaya I.V., Osmanov D.S., Probatova N.A., Tupitsin N.N., Kruglova G.V., Kuril'nikov A.Y., Sholokhova E.N., Manzyuk L.V., Borodkina A.G., Shirin A.D., Unukova E.N., Zeynalova P.A., Byalik T.E., Sorokin E.N., Petrov O.A.
|
| Vol 13, No 3 (2011) |
Novye vozmozhnostiv lechenii raka pryamoy kishki |
|
|
Artamonova E.V.
|
| Vol 10, No 4 (2008) |
Novyy shag k prodleniyu zhizni bol'nykh metastaticheskim rakom pecheni |
|
|
- -.
|
| Vol 4, No 1 (2002) |
Novyy vek - novye vozmozhnosti khimioterapii: temodal v lechenii zlokachestvennykh opukholey |
|
|
Poddubnaya I.V.
|
| Vol 14, No 3 (2012) |
Novyy vzglyad na biologicheskie osobennosti pervichnoy ekstranodal'noy diffuznoy V-krupnokletochnoy limfomy |
|
|
Subortseva I.N., Kovrigina A.M., Korobko I.V., Poddubnaya I.V.
|
| Vol 5, No 3 (2003) |
Novyy vzglyad na neoad\"yuvantnuyu khimioterapiyu raka molochnoy zhelezy (rol' navel'bina) |
|
|
Semiglazov V.F., Arzumanov A.S., Bozhok A.A., Paltuev R.M., Topuzov E.E., Semiglazov V.V., Klettsel' A.A., Nurgaziev K.S., Ivanova O.A., Petrovskiy S.G.
|
| Vol 18, No 4 (2016) |
Nutritional status of children with cancer and hematological malignancies during treatment in FSBI Federal Scientific Clinical Center of Pediatric Hematology, Oncology and Immunology named after Dmitry Rogachev (screening results) |
|
|
Vasilyeva E.S., Vashura A.Y., Litvinov D.V.
|
| Vol 25, No 2 (2023) |
Nutritional support for primary patients with esophageal cancer (analytical review) |
(Rus)
|
|
Obukhova O.A., Kurmukov I.A., Abu-Khaidar O.B.
|
| Vol 25, No 3 (2023) |
Nutritional support in oncology: the place of parenteral nutrition (literature review) |
(Rus)
|
|
Pasechnik I.N., Skobelev E.I., Boldyreva T.S.
|
| Vol 24, No 1 (2022) |
Nutritional support in the perioperative period of treatment of cancer patients: Retrospective cohort study |
(Rus)
|
|
Gameeva E.V., Stepanovna A.M., Khoronenko V.E., Gridnev O.V., Sviridov S.V., Shestopalov A.E.
|
| Vol 14, No 4 (2012) |
Obrazovatel'nye meropriyatiyav oblasti abdominal'noy onkologii |
|
|
- -.
|
| Vol 12, No 3 (2010) |
Obzor konferentsii ekspertovv oblasti lekarstvennoy terapii rakapochki «Novye vozmozhnosti v terapiimetastaticheskogo raka pochki» |
|
|
Volkova L.Y.
|
| Vol 7, No 2 (2005) |
Odnomomentnoe udalenie dvukh metastazov raka legkogo iz raznykh oblastey golovnogo mozga |
|
|
Karakhan V.B., Aleshin V.A., Fu R.G., Krat V.B.
|
| Vol 9, No 3 (2007) |
Odnomomentnye mastektomii i laparoskopicheskie ovariektomii v lechenii raka molochnoy zhelezy |
|
|
Khvastunov R.A., Kireev A.V., Nikol'skiy I.V., Suvorov V.A.
|
| Vol 20, No 3 (2018) |
Olaparib in the maintenance treatment of platinum-sensitive relapse of BRCA mutant ovarian cancer in routine clinical practice: first results of observational study in Russian patients |
(Rus)
|
|
Artamonova E.V., Kovalenko E.I., Snegovoy A.V., Aksarin A.A., Anciferova T.A., Belonogov A.V., Bilan E.V., Bilenko S.N., Varvus I.M., Gorkovenko E.A., Enikeev R.F., Ermolaeva A.M., Kramskaya L.V., Kononenko I.B., Pechenyy A.P., Safina S.Z., Chupriyanova T.V., Chuhua G.G., Shemyakina A.I., Shikina E.V.
|
| Vol 19, No 3 (2017) |
Olaparib maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer |
(Rus)
|
|
Khokhlova S.V.
|
| Vol 18, No 5 (2016) |
On the question of the treatment of chronic hepatitis C with HIV co-infection in patients with lymphoma |
|
|
Chistyakova A.V., Stuklov N.I., Tumanova M.V., Dubnitskaya M.G., Mukhin O.V., Shtyrlina E.P., Pivnik A.V.
|
| Vol 7, No 1 (2005) |
Opioidnyy anal'getik tsentral'nogo deystviya tramadola gidrokhlorid (tramal) pri lechenii khronicheskoy boli u onkologicheskikh bol'nykh |
|
|
Isakova M.E., Pavlova Z.V., Bryuzgin V.V.
|
| Vol 14, No 1 (2012) |
Opisanie klinicheskikhsluchaev primeneniya kombinatsiys lapatinibom v lecheniiHER2-pozitivnogo rasprostranennogoraka molochnoy zhelezy |
|
|
Bolotina L.V., Kramskaya L.V., Smirnova I.A., Zharikova I.A., Aminov G.G.
|
| Vol 23, No 1 (2021) |
Opportunities for metastatic triple negative breast cancer therapy |
(Rus)
|
|
Ganshina I.P., Gordeeva O.O., Manukyan M.S.
|
| Vol 24, No 4 (2022) |
Opportunities of ICG-fluorescent imaging of lymph nodes during radical cystectomy in patients with bladder cancer: A review |
(Rus)
|
|
Pavlov V.N., Urmantsev M.F., Bakeev M.R.
|
| Vol 21, No 1 (2019) |
Opportunities of the pharmacogenetic approach to personalized tamoxifen breast cancer therapy: case reports |
(Rus)
|
|
Savelyeva M.I., Dudina I.A., Zaharenkova J.S., Ignatova A.K., Ryzhikova K.A., Sozaeva Z.A., Kudlay D.A., Perfileva O.M., Poddubnaya I.V.
|
| Vol 13, No 1 (2011) |
Opredelenie HER2/neu-statusa po gistologicheskomu materialu -est' li prostranstvo dlya diskussii? |
|
|
Borbat A.M., Tkachenko E.V., Pozharisskiy K.M.
|
| Vol 20, No 2 (2018) |
Optimal duration of adjuvant trastuzumab therapy in patients with HER2-possitive early breast cancer: whether the problem is resolved? |
(Rus)
|
|
Zhukova L.G., Ganshina I.P., Khatkova E.I., Tikhomirova T.E., Kondratyeva O.E.
|
| Vol 6, No 2 (2004) |
Optimizatsiya kombinirovannogo lecheniya bol'nykh mestno-rasprostranennym rakom gortanoglotki |
|
|
Madzhidov M.G.
|
| Vol 12, No 4 (2010) |
Optimizatsiya metodov lecheniyakhronicheskogo bolevogo sindroma u bol'nykhs metastazami v kosti disseminirovannogoraka molochnoy zhelezy |
|
|
Kogoniya, L.M., Mos'kin V.G.
|
| Vol 14, No 1 (2012) |
Opukhol' Abrikosova:porazhenie legkikh u rebenka 4 let |
|
|
Seroklinov V.N., Kozhevnikov V.A., Chursin A.A., Bylina E.A., Logvinova T.V., Drachev V.V., Starodubtsev E.G., Mizernitskiy Y.L.
|
| Vol 13, No 1 (2011) |
Opyt dlitel'nogo primeneniya kombinatsii kapetsitabina, lapatiniba i trastuzumabapri HER-2-pozitivnom metastaticheskom rake molochnoy zhelezy. Opisanie klinicheskogo sluchaya |
|
|
Zhukova L.G., Okruzhnova M.A., Lubennikova E.V., Zeynalova K.R.
|
| Vol 12, No 1 (2010) |
Opyt GNTs RAMN po primeneniyunilotiniba (Tasigna) u bol'nykhv khronicheskoy faze khronicheskogomieloleykoza pri neudache terapiiimatinibom |
|
|
Gusarova G.A., Turkina A.G., Domracheva E.V., Tikhonova L.Y., Egorova M.O., Kolosheynova T.I., Stakhina O.V., Nemchenko I.S., Vakhrusheva M.V., Chelysheva E.Y., Zakharova E.S., Goryacheva S.R., Sokolova M.A., Kuznetsov S.V., Afanas'eva N.A., Khoroshko N.D.
|
| Vol 12, No 1 (2010) |
Opyt lecheniya kapetsitabinomi trastuzumabom metastaticheskogoporazheniya golovnogo mozga pri rakemolochnoy zhelezy s giperekspressieyHer-2/neu |
|
|
Naskhletashvili D.R., Chmutin G.E., Karakhan V.B., Aleshin V.A., Fu R.G., Moskvina E.A., Belov D.M., Luk'yanchenko A.B., Ivanova E.A.
|
| Vol 12, No 1 (2010) |
Opyt lecheniya stromal'nykh opukholeyzheludochno-kishechnogo traktav Chelyabinskoy oblasti |
|
|
Antonov A.A., Nadvikova E.A., Vazhenin A.V.
|
| Vol 5, No 1 (2003) |
Opyt primeneniya abitaksela™ v lechenii solidnykh opukholey |
|
|
Blyumenberg A.G., Gutorov S.L., Topchieva S.V., Gorbunova V.A., Lichinitser M.R.
|
| Vol 12, No 3 (2010) |
Opyt primeneniya Avastina (bevatsizumaba)v sochetanii s khimioterapiey v lecheniirasprostranennykh form nemelkokletochnogoraka legkogo v otdelenii torakal'noyonkologii |
|
|
Orlov S.V., Stel'makh L.V., Lozhkina A.M., Poltoratskiy A.N.
|
| Vol 14, No 3 (2012) |
Opyt primeneniya bendamustina u patsientov s retsidivom khronicheskogo limfoleykoza v rezhime monoterapii v ambulatornykh usloviyakh |
|
|
Ivashchenko A.V.
|
| Vol 13, No 1 (2011) |
Opyt primeneniya gefitiniba v lechenii nemelkokletochnogo raka legkikh v Orlovskoy oblasti |
|
|
Golubenko R.A., Gromov G.B., Vishnevskiy V.I.
|
| Vol 14, No 4 (2012) |
Opyt primeneniya kapetsitabina v neoad\"yuvantnoy khimioterapii raka molochnoy zhelezy |
|
|
Slonimskaya E.M., Tarabanovskaya N.A., Bragina O.D., Garbukov E.Y., Doroshenko A.V., Kokorina Y.L., Zav'yalova M.V.
|
| Vol 11, No 1 (2009) |
Opyt primeneniya kapetsitabinau bol'nykh rakom molochnoy zhelezy s metastazami v golovnoy mozg |
|
|
Naskhletashvili D.R., Chmutin G.E., Karakhan V.B., Aleshin V.A., Fu R.G., Belov D.M., Ivanova E.A.
|
| Vol 10, No 2 (2008) |
Opyt primeneniya preparata Eloksatin pri kolorektal'nom rake |
|
|
Voznyy E.K., Popov A.Y., Astrakhankina T.A., Grishunenkova E.P., Polyanskaya E.V.
|
| Vol 9, No 2 (2007) |
Opyt primeneniya preparata Vero-kladribin u bol'nykh volosatokletochnym leykozom |
|
|
Al'-Radi L.S., Moiseeva T.N., Kravchenko S.K.
|
| Vol 7, No 1 (2005) |
Opyt primeneniya Regional'noy programmy v g. Krasnodare |
|
|
Mitashok I.S.
|
| Vol 4, No 3 (2002) |
Opyt primeneniya taksola v khimioterapii ploskokletochnogo raka golovy i shei |
|
|
Podvyaznikov S.O., Byakhov M.Y.
|
| Vol 8, No 1 (2006) |
Opyt primeneniya Taksotera v kombinatsii s doksorubitsinom v kachestve khimioterapii 1-y linii u bol'nykh metastaticheskim rakom molochnoy zhelezy |
|
|
Samoylenko V.M., Gorbunova V.A., Koshelev M.N., Yurashko K.V.
|
| Vol 15, No 3 (2013) |
Opyt primeneniya Votrienta v kombinirovannom lechenii redkikh mestno-rasprostranennykh sarkom myagkikh tkaney vysokoy stepeni zlokachestvennosti |
|
|
Zubarev A.L., Kuril'chik A.A., Starodubtsev A.L., Ivanov V.E.
|
| Vol 8, No 1 (2006) |
Opyt primeneniya vysokodoznoy khimioterapii pri retsidiviruyushchem techenii i refrakternykh formakh limfomy Khodzhkina (retrospektivnyy analiz dannykh chetyrekh transplantatsionnykh tsentrov Respubliki Belarus', Rossiyskoy Federatsii i Ukrainy) |
|
|
Zhukov N.V., Uss A.L., Afanas'ev B.V., Karamanesht E.E., Ptushkin V.V.
|
| Vol 8, No 2 (2006) |
Opyt profilakticheskogo primeneniya rekombinantnogo faktora Vila dlya umen'sheniya intraoperatsionnykh krovotecheniy u onkologicheskikh bol'nykh |
|
|
Barkagan Z.S., Khodorenko S.A., Mamaev A.N., Nazarov A.V., Mamaeva I.V., Tsyvkina L.P., Rossokha A.V.
|
| Vol 14, No 4 (2012) |
Opyt provedeniya nablyudatel'nykhprogramm v abdominal'noy onkologii |
|
|
- -.
|
| Vol 3, No 2 (2001) |
Opyt trakheobronkhoplasticheskikh operatsiy pri opukholyakh legkikh i trakhei |
|
|
Novikov E.A., Aminodov S.A., Solov'ev V.G., Smirnov A.V.
|
| Vol 14, No 2 (2012) |
Opyt uspeshnogo lecheniya HER2-pozitivnogo metastaticheskogo raka zheludka |
|
|
Gamayunov S.V., Slugarev V.V., Ter-Ovanesov M.D., Zakharova E.M.
|
| Vol 22, No 4 (2020) |
Oral anticoagulation in people with cancer who have no therapeutic or prophylactic indication for anticoagulation (Russian Translation of Cochrane Plain Language Summary – PLS) |
(Rus)
|
|
Alexandrova E.G.
|
| Vol 5, No 3 (2003) |
Oral'nyy vepezid v lechenii retsidivov i platinorezistentnykh form raka yaichnikov (opyt primeneniya) |
|
|
Makhnova E.V.
|
| Vol 5, No 1 (2003) |
Organizatsionno-metodicheskie aspekty realizatsii Regional'noy programmy lecheniya mestno-rasprostranennogo i metastaticheskogo raka molochno y zhelezy s ispol'zovaniem rezhima dotsetaksel/doksorubitsin |
|
|
Podregul'skiy K.E., Poddubnaya I.V.
|
| Vol 3, No 1 (2001) |
Organosokhranyayushchee lechenie - perspektivnoe napravlenie razvitiya onkopediatrii XXI veka |
|
|
Durnov L.A., Sharoev T.A., Polyakov V.G., Ivanova N.M., Lebedev V.I., Pashkov Y.V., Bondar' I.V., Belkina B.M., Boychenko E.I.
|
| Vol 12, No 1 (2010) |
Original'naya kombinatsiyaFtorafur® + vinorelbinv lechenii raka molochnoy zhelezy:pervye rezul'taty |
|
|
Manzyuk L.V., Artamonova E.V., Satirova E.F., Alatortseva E.S.
|
| Vol 8, No 3 (2006) |
Ortopedicheskaya reabilitatsiya onkologicheskikh bol'nykh s defektami verkhney chelyusti |
|
|
Chuykov M., Matyakin E.G., Azizyan R.I., Akhundov A.A., Mudunov A.M., Podvyaznikov O., Fedotov N.N., Chuchkov M.V., Agapov V.V.
|
| Vol 24, No 1 (2022) |
Osimertinib and routine practice: the experience of the drug application in different clinical situations in case of metastatic non-small cell lung cancer with an EGFR mutation. Case report |
(Rus)
|
|
Orlov S.V., Baldin P.L., Diuzeva N.V., Krechetova A.V., Mordovskiy A.A., Moskovchenko A.N., Musaeva N.E., Romanchuk O.V.
|
| Vol 21, No 3 (2019) |
Osimertinib for the first-line treatment of EGFR-positive non-small cell lung cancer |
(Rus)
|
|
Reutova E.V., Laktionov K.P., Iudin D.I., Neliubina L.A., Gorokhova G.K., Egorova A.V.
|
| Vol 7, No 2 (2005) |
Osnovnye aspekty primeneniya bisfosfonatov v onkologii |
|
|
Kondrat'eva A.P.
|
| Vol 5, No 2 (2003) |
Osnovnye napravleniya sovremennoy luchevoy terapii zlokachestvennykh opukholey |
|
|
Kondrat'eva A.P.
|
| Vol 5, No 4 (2003) |
Osnovnye problemy optimizatsii okazaniya onkologicheskoy pomoshchi naseleniyu( Yakutsk, 1992 - 2002 gg.) |
|
|
Poddubnaya I.V., Aksel' E.M., Ivanov P.M., Ivanova R.I., Kipriyanova N.S., Afanas'eva L.N.
|
| Vol 8, No 4 (2006) |
Osobennosti klinicheskogo techeniya i prognoz bol'nykh nekhodzhkinskoy limfomoy s pervichnoy lokalizatsiey v yaichke |
|
|
Tumyan G.S., Kovrigina A.M., Timofeeva O.L., Probatova N.A., Sholokhova E.N., Tupitsyn N.N., Poddubnaya I.V., Osmanov D.S.
|
| Vol 8, No 3 (2006) |
Osobennosti kliniko-morfologicheskikh kharakteristik i lecheniya retsidiva raka yaichnikov IV stadii |
|
|
Mel'ko A.I., Ushakov I.I., Kira E.F., Shamkina V.O., Gaytukieva R.A.
|
| Vol 17, No 3 (2015) |
Osobennosti korrektsii naibolee chastykh nezhelatel'nykh yavleniy na fone primeneniya ingibitorov BRAF i MEK |
|
|
Samoylenko I.V.
|
| Vol 4, No 4 (2002) |
Osobennosti lecheniya bol'noy neorgannoy pleomorfnoy liposarkomoy |
|
|
Blyumenberg A.G., Kuznetsov V.V., Gorbunova V.A., Mikhina Z.P., Borisov V.I., Gubin A.N., Poddubnyy B.K., Petrovichev N.N., Kiselevskiy M.V., Zakharova T.I., Kireev A.V., Vakurova E.S., Rotin D.L.
|
| Vol 9, No 3 (2007) |
Osobennosti profilaktiki posleoperatsionnykh tromboembolicheskikh oslozhneniy u patsientov so zlokachestvennymi zabolevaniyami |
|
|
Pashanov E.D., Zamyatin M.N., Stoyko Y.M., Rumyantsev A.G.
|
| Vol 17, No 3 (2015) |
Osobennosti profilya toksichnosti ingibitorov BRAF i MEK |
|
|
Protsenko S.A.
|
| Vol 10, No 3 (2008) |
Osobennosti reproduktivnoy funktsii u zhenshchin s onkogematologicheskimi zabolevaniyami |
|
|
Shmakov R.G., Polushkina E.S.
|
| Vol 5, No 2 (2003) |
Osobennosti serdechno-dykhatel'nogo sinkhronizma u zhenshchin s razlichnym tonusom vegetativnoy nervnoy sistemy na etape postanovki onkologicheskogo diagnoza |
|
|
Arkad'eva T.V., Selyan N.A.
|
| Vol 13, No 3 (2011) |
Osteopontin, CD55:prognosticheskie faktory riskapri rake molochnoy zhelezy |
|
|
Guzieva Z.M., Poddubnaya I.V., Vishnevskaya Y.V., Makarenko N.P., Sytenkova K.V.
|
| Vol 10, No 3 (2008) |
Ot glavnogo redaktora Uvazhaemye kollegi! |
|
|
Poddubnaya I.V.
|
| Vol 11, No 3 (2009) |
Otdalennye rezul'taty khirurgicheskogo lecheniya gastrointestinal'nykh stromal'nykh opukholey zheludochno-kishechnogo trakta |
|
|
Istomin Y.V., Evdokimov M.Y.
|
| Vol 7, No 3 (2005) |
Otkrytaya mnogotsentrovaya programma po otsenke effektivnosti i bezopasnosti kombinirovannoy terapii myustoforanom, tsisplatinom, tamoksifenom patsientov s disseminirovannoy zlokachestvennoy melanomoy |
|
|
Konstantinova M.M., Gershanovich M.L., Akimov M.A., Nosov D.A., Bogdanova N.V.
|
| Vol 3, No 1 (2001) |
Otkrytoe nesravnitel'noe issledovanie gikamtina v kachestve terapii II linii pri rake yaichnikov. Lechenie retsidivov raka yaichnikov gikamtinom - opyt rossiyskikh regionov (predvaritel'naya otsenka neposredstvennykh rezul'tatov) |
|
|
Poddubnaya I.V., Khasanov R.S., Ruchkin V.N., Lazarev A.N., Byakhov M.Y., Vtoraya O.M., Yurchenko V.S.
|
| Vol 14, No 2 (2012) |
Otsenka effektivnosti i perenosimosti abiraterona atsetata (Zitiga) u patsientov s metastaticheskim gormonorezistentnym rakom predstatel'noy zhelezy, u kotorykh otmechalas' progressiya opukholevogo protsessa posle khimioterapii taksanami |
|
|
Gafanov R.A., Ivanov S.A., Fastovets S.V., Isaev T.K.
|
| Vol 11, No 3 (2009) |
Otsenka effektivnostii bezopasnosti fotemustinav monorezhime i v kombinatsii s proizvodnymi platiny(karboplatinom ili tsisplatinom) pri lechenii disseminirovannoy melanomy |
|
|
Konstantinova M.M., Savkova R.F., Demidov L.V., Gorbunova V.A., Kharkevich G.Y., Antimonik N.Y., Merkulov V.N., Simanovich E.E., Ral'chenko K.V., Sbrodov O.V.
|
| Vol 3, No 4 (2001) |
Otsenka toksichnosti protivoopukholevogo preparata gemtsitabina (GEM) |
|
|
Mamedov F.F., Narimanov M.N., Bazin I.S., Efimov O.N., Zharkov S.A., Tryakin A.A., Tyulyandin S.A., Garin A.M.
|
| Vol 23, No 2 (2021) |
Outcomes of neoadjuvant chemotherapy in resectable, borderline resectable and locally advanced pancreatic cancer |
(Rus)
|
|
Dalgatov K.D., Semenov N.N., Kozodaeva M.V.
|
| Vol 18, No 1 (2016) |
Outcomes of surgical treatment of advanced gastrointestinal stromal tumors |
(Rus)
|
|
Abouhaidar O.B., Nered S.N., Arkhiri P.P., Nikulin M.P., Stilidi I.S.
|
| Vol 16, No 1 (2014) |
Overcoming immunological tolerance is a way of treating malignant tumors: new perspectives |
|
|
Samoilenko I.V., Kharkevich G.U., Demidov L.V.
|
| Vol 24, No 2 (2022) |
Own experience in the treatment of primary refractory Hodgkin's lymphoma. Case report |
(Rus)
|
|
Gushchina E.E., Vernyuk M.A., Chervontseva A.M., Cherkashina I.V., Khayrullina L.S., Lunin V.V., Fedenko A.A.
|
| Vol 19, No 1 (2017) |
Own experience of treatment by epoetin-α (Eralfon®) of chemotherapy induced anemia |
(Rus)
|
|
Bolshakova S.A., Bychkov Y.M., Kazarova M.V.
|
| Vol 24, No 1 (2022) |
Own Experience of Using Lenvatinib in Patients with Advanced Hepatocellular Carcinoma in Real Clinical Practice based on Moscow City Oncological Hospital №62 |
(Rus)
(Eng)
|
|
Volkonsky M.V., Zhikhorev R.S., Makarkina T.A., Filippova V.M., Vasileva Y.V., Akopyan A.A., Zhelezkova T.A.
|
| 601 - 700 of 1301 Items |
<< < 1 2 3 4 5 6 7 8 9 10 11 12 13 14 > >> |
